This inventor holds 1 USPTO granted patent. Top assignee: Novo Nordisk A/s. Active years: 2000.
Company Filing History:
Years Active: 2000
Title: Thomas Schafer: Innovator in Microbial Transglutaminases
Introduction
Thomas Schafer is a notable inventor based in Farum, Germany. He has made significant contributions to the field of biotechnology, particularly in the area of microbial transglutaminases. His work has implications for various applications in food technology and pharmaceuticals.
Latest Patents
Thomas Schafer holds a patent for "Microbial transglutaminases, their production and use." This patent highlights his innovative approach to utilizing microbial enzymes in various industrial processes. The patent showcases his expertise and commitment to advancing biotechnological solutions.
Career Highlights
Thomas Schafer is currently employed at Novo Nordisk A/S, a leading global healthcare company. His role at Novo Nordisk allows him to work on cutting-edge research and development projects that aim to improve health outcomes for patients worldwide. His dedication to innovation is evident in his contributions to the company's mission.
Collaborations
Throughout his career, Thomas has collaborated with esteemed colleagues such as Torben Halkier and Lisbeth Bech. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their work.
Conclusion
In summary, Thomas Schafer is a distinguished inventor whose work in microbial transglutaminases has made a significant impact in biotechnology. His contributions at Novo Nordisk A/S and collaborations with fellow researchers underscore his commitment to innovation and excellence in the field.